Visit COVID-19 resources

[Skip to Content]

In vivo biocompatibility of a new cyanine dye for ILM peeling – (Eye 29, 428 (March 2015))

Mar 12
2015

In vivo biocompatibility of a new cyanine dye for ILM peeling Eye 29, 428 (March 2015). doi:10.1038/eye.2014.295 Authors: S Thaler, C Haritoglou, F Schuettauf, T Choragiewicz, C A May, F Gekeler, M D Fischer, H Langhals & A Schatz

  • 12 March 2015

Effects of intravitreal injection of bevacizumab on nitric oxide levels – (Eye 29, 436 (March 2015))

Mar 12
2015

Effects of intravitreal injection of bevacizumab on nitric oxide levels Eye 29, 436 (March 2015). doi:10.1038/eye.2014.297 Authors: E Dinc, O Yildirim, L Ayaz, T Ozcan & S N Yilmaz

  • 12 March 2015

Myopic foveoschisis: a clinical review – (Eye Journal AOP)

Mar 06
2015

Myopic foveoschisis: a clinical review Eye advance online publication, March 6 2015. doi:10.1038/eye.2014.311 Authors: R Gohil, S Sivaprasad, L T Han, R Mathew, G Kiousis & Y Yang

  • 6 March 2015

Implantation of refractive multifocal intraocular lens with a surface-embedded near section for cataract eyes complicated with a coexisting ocular pathology – (Eye Journal AOP)

Mar 06
2015

Implantation of refractive multifocal intraocular lens with a surface-embedded near section for cataract eyes complicated with a coexisting ocular pathology Eye advance online publication, March 6 2015. doi:10.1038/eye.2015.12 Authors: M Ouchi & S Kinoshita

  • 6 March 2015

Botulinum toxin injection for the treatment of epiphora in lacrimal outflow obstruction – (Eye Journal AOP)

Mar 06
2015

Botulinum toxin injection for the treatment of epiphora in lacrimal outflow obstruction Eye advance online publication, March 6 2015. doi:10.1038/eye.2015.18 Authors: K Ziahosseini, Z Al-Abbadi & R Malhotra

  • 6 March 2015